共 50 条
- [21] The essential role of PI3Kδ and PI3Kγ in thymocyte survivalJOURNAL OF IMMUNOLOGY, 2006, 176 : S313 - S313Diacovo, ThomasMontgrain, VivianneDoggett, TeresaDouangpanya, JasonPuri, KamalVermi, WilliamSwat, Wojciech
- [22] PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory DiseasesJOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8559 - 8581Cushing, Timothy D.Metz, Daniela P.Whittington, Douglas A.McGee, Lawrence R.
- [23] The essential of PI3Kγ and PI3Kδ in thymocyte survival.BLOOD, 2005, 106 (11) : 63B - 63BDiacovo, TGVermi, WMontgrain, VDouangpanya, JDoggett, TPuri, KSwat, W
- [24] Regulation of T cell alloimmunity by PI3Kγ and PI3KδNATURE COMMUNICATIONS, 2017, 8Uehara, MayukoMcGrath, Martina M.Ohori, ShunsukeSolhjou, ZhabizBanouni, NaimaRoutray, SujitEvans, CatherineDiNitto, Jonathan P.Elkhal, AbdallahTurka, Laurence A.Strom, Terry B.Tullius, Stefan G.Winkler, David G.Azzi, JamilAbdi, Reza
- [25] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancerCurrent Breast Cancer Reports, 2014, 6 (2) : 59 - 70Huemer F.Bartsch R.Gnant M.
- [26] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial CancerCURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080Chen, JiezhongZhao, Kong-NanLi, RuiShao, RenfuChen, Chen
- [29] PI3K inhibitors in inflammation, autoimmunity and cancerCURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 82 - 91Stark, Anne-KatrienSriskantharajah, SrividyaHessel, Edith M.Okkenhaug, Klaus
- [30] Targeting the PI3K pathway for cancer therapyFUTURE MEDICINAL CHEMISTRY, 2012, 4 (09) : 1153 - 1169Sadeghi, NavidGerber, David E.